Company page
Kane Biotech Inc.
Kane Biotech Inc. is a public company listed under the ticker KNE on the Canadian market. The company has a market capitalization of approximately CAD 3.65 million. Kane Biotech focuses on developing innovative solutions for the prevention and treatment of biofilm-related infections.
- Ticker
- KNE:TSXV
- Asset type
- Stock
- Market cap
- $3.7M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- TSXV
- Currency
- CAD